Figure 1.
OS and PFS analyses of patients who received IC or ven/aza. Median OS (A) and PFS (B) of patients who received ven/aza (red) vs those who received IC (blue). In a cohort of patients propensity matched for age, ELN risk group, and transplantation status, median OS (C) and PFS (D) of patients who received ven/aza (red) vs those who received IC (blue).